HARVARD BIOSCIENCE, INC. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
HARVARD BIOSCIENCE, INC. (HBIO) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $2.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-13
- HARVARD BIOSCIENCE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for the quarter ending 2016-09-30 was $600.00K.
- HARVARD BIOSCIENCE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $2.10M, a 16.00% decline from fiscal 2024.
- HARVARD BIOSCIENCE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was $2.50M, a 257.14% increase from fiscal 2023.
- HARVARD BIOSCIENCE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $700.00K, a 250.00% increase from fiscal 2022.
- HARVARD BIOSCIENCE, INC. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was $200.00K.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 9 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month as first filed |
|---|---|---|---|---|
| 2025-12-31 | $2.10M 10-K · filed 2026-03-13 | |||
| 2024-12-31 | $2.50M 10-K · filed 2026-03-13 | |||
| 2023-12-31 | $700.00K 10-K · filed 2025-03-14 | |||
| 2022-12-31 | $200.00K 10-K · filed 2024-03-07 | -$200.00K 10-K · filed 2023-03-09 | ||
| 2021-12-31 | -$2.00M 10-K · filed 2023-03-09 | |||
| 2020-12-31 | $2.90M 10-K · filed 2022-03-11 | |||
| 2019-12-31 | -$200.00K 10-K/A · filed 2021-03-17 | |||
| 2018-12-31 | $2.50M 10-K · filed 2020-03-16 | |||
| 2017-12-31 | $500.00K 10-K · filed 2018-03-16 | |||
| 2016-09-30 | $600.00K 10-Q · filed 2016-11-03 | $600.00K 10-Q · filed 2016-11-03 | ||
| 2015-12-31 | $16.40M 10-K · filed 2018-03-16 | $16.70M 10-K · filed 2016-04-29 | ||
| 2014-12-31 | $1.30M 10-K · filed 2015-03-12 | |||
| 2010-12-31 | $11.30M 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |